Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: A randomized trial

Sewon Kang, Michael T. Goldfarb, Jonathan S. Weiss, Russell D. Metz, Ted A. Hamilton, John J. Voorhees, Christopher E.M. Griffiths

Research output: Contribution to journalArticle

Abstract

Background: Adapalene is a synthetic retinoid with an established clinical efficacy against acne and good local tolerability. Its effectiveness in the treatment of photodamaged skin has not been studied. Objective: We sought to determine the safety and efficacy of adapalene gel in the treatment of actinic keratoses and solar lentigines. Methods: In a prospective, 2-center, randomized, controlled, investigator-masked, parallel-group study, 90 patients with actinic keratoses and solar lentigines were treated daily with either adapalene gel (0.1% or 0.3%) or its vehicle gel for 4 weeks, followed by twice-daily applications, if tolerated, for up to 9 months. Results: Of the 90 Caucasian patients (69 male, 21 female; mean age 63.1 years) who were enrolled into the study, 83 patients completed 9 months of treatment. With adapalene gel 0.1% and 0.3%, the mean number of actinic keratoses was reduced by 0.5 ± 0.9 (mean ± SE) and 2.5 ± 0.9, respectively. Whereas, with the vehicle gel, there was an increase of 1.5 ± 1.3 (P < .05). After 1 month of treatment, the patients who received adapalene had significant lightening of solar lentigines as compared with the patients who were treated with vehicle gel (P < .05). After 9 months, 57% and 59% of the patients had lighter lesions in the adapalene 0.1% and 0.3% groups, respectively, in comparison with only 36% in the vehicle group (P < .05). Histologic evaluations revealed improved cellular atypia and reduced epidermal melanin in adapalene-, as compared with vehicle-treated group. The differences, however, were not statistically significant. A retrospective evaluation of paired clinical photographs (before and after 9-month treatment) by 2 dermatologists who were treatment-blinded revealed significant improvement in wrinkles and other clinical features of photoaged skin with adapalene as compared with its vehicle. Conclusion: Adapalene gel 0.1% and 0.3% were well tolerated and improved actinic keratoses, solar lentigines, and other features of photodamaged skin.

Original languageEnglish (US)
Pages (from-to)83-90
Number of pages8
JournalJournal of the American Academy of Dermatology
Volume49
Issue number1
DOIs
StatePublished - Jul 1 2003
Externally publishedYes

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: A randomized trial'. Together they form a unique fingerprint.

  • Cite this

    Kang, S., Goldfarb, M. T., Weiss, J. S., Metz, R. D., Hamilton, T. A., Voorhees, J. J., & Griffiths, C. E. M. (2003). Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: A randomized trial. Journal of the American Academy of Dermatology, 49(1), 83-90. https://doi.org/10.1067/mjd.2003.451